Yuichiro Izumi Selected Research

Yuichiro Izumi Research Topics

Disease

4	Hypertension (High Blood Pressure) 10/2023 - 08/2021
4	Proteinuria 10/2023 - 08/2021
4	Acidosis 11/2019 - 09/2009
3	Chronic Renal Insufficiency 03/2024 - 01/2016
3	Hypoxia (Hypoxemia) 02/2022 - 06/2014
3	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 11/2015 - 04/2011
3	Dehydration (Water Stress) 10/2014 - 04/2007
2	Reperfusion Injury 01/2024 - 01/2022
2	Fibrosis (Cirrhosis) 07/2023 - 01/2017
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2021 - 11/2019
2	Albuminuria 11/2020 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2014
2	Neoplasms (Cancer) 11/2018 - 11/2016
2	Arteriovenous Malformations (Arteriovenous Malformation) 06/2018 - 04/2014
1	Anemia 02/2022
1	Thrombosis (Thrombus) 01/2022
1	Ischemia 01/2022
1	Hemorrhage 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Rodent Diseases 08/2021
1	Wounds and Injuries (Trauma) 08/2021
1	Disease Progression 11/2020
1	Premature Aging 01/2020
1	Sensorineural Hearing Loss 01/2020
1	Overweight 11/2019
1	Obesity 11/2019
1	Body Weight (Weight, Body) 11/2018
1	Infections 11/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 10/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hyponatremia 11/2015
1	Leiomyoma (Uterine Fibroids) 08/2015
1	Infarction (Infarctions) 08/2015
1	Hepatocellular Carcinoma (Hepatoma) 07/2012
1	Necrosis 07/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2007
8	Messenger RNA (mRNA)IBA 07/2023 - 04/2007
4	Erythropoietin FDA Link 01/2024 - 06/2014
3	SaltsIBA 10/2023 - 11/2021
3	camostatIBA 10/2023 - 08/2021
3	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2023 - 08/2021
3	CreatinineIBA 01/2022 - 01/2016
3	AldosteroneIBA 11/2015 - 04/2011
3	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2012 - 04/2007
3	Vasopressins (Vasopressin)IBA 10/2012 - 04/2007
2	roxadustatIBA 01/2024 - 02/2022
2	Fibrinolysin FDA Link 10/2023 - 01/2023
2	EnzymesIBA 07/2023 - 02/2022
2	Ammonium CompoundsIBA 11/2019 - 04/2011
2	AcidsIBA 11/2019 - 06/2009
2	EnbucrilateIBA 06/2018 - 04/2014
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2024
1	SulfotransferasesIBA 07/2023
1	IndicanIBA 07/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	HematinicsIBA 02/2022
1	Lipocalin-2IBA 01/2022
1	Valosin Containing ProteinIBA 01/2022
1	KUS121IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 08/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	nephrinIBA 11/2020
1	LigandsIBA 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	Sodium Chloride FDA LinkGeneric 11/2019
1	Drinking WaterIBA 11/2018
1	Doxycycline (Periostat)FDA LinkGeneric 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Cisplatin (Platino)FDA LinkGeneric 11/2018
1	Tetracycline (Achromycin)FDA LinkGeneric 11/2018
1	Polidocanol (Laureth)FDA Link 06/2018
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	UbiquitinIBA 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	ChromatinIBA 11/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2015
1	GelatinIBA 08/2015
1	Member 1 Solute Carrier Family 12IBA 10/2014
1	Protein Isoforms (Isoforms)IBA 10/2014
1	ethanolamine oleate (Ethamolin)FDA Link 04/2014
1	AngiotensinsIBA 01/2014
1	Proton-Translocating ATPases (ATPase, H+)IBA 04/2011
1	MineralocorticoidsIBA 04/2011
1	Adenosine Triphosphatases (ATPase)IBA 04/2011
1	FludrocortisoneIBA 04/2011
1	ElectrolytesIBA 09/2009

Therapy/Procedure

2	Therapeutics 03/2024 - 01/2016
2	Sclerotherapy 06/2018 - 04/2014
1	Bed Rest (Bedrest) 01/2023
1	Stents 01/2022
1	Renal Dialysis (Hemodialysis) 01/2020
1	Endovascular Aneurysm Repair 10/2017
1	Uterine Artery Embolization 08/2015
1	Electrodes (Electrode) 07/2012
1	Radiofrequency Ablation 07/2012